Stock Market Today: Stocks Slide as Regional Bank Rout Worsens
The major market indexes closed lower Thursday as chaos in the banking industry continued.
Panic selling in regional bank stocks resulted in losses for the major indexes Thursday.
PacWest Bancorp (PACW) suffered the most devastating decline, shedding half its value after the California-based lender said in a statement it is considering "strategic asset sales," and "will evaluate all options to maximize shareholder value." There were plenty of other headlines for investors to consider today, too, like the biggest initial public offering (IPO) in almost two years and a busy earnings calendar.
Although today's slide in PACW shares garnered the most attention, it was hardly the only regional bank stock that got hit with sizable losses. Western Alliance (WAL) tumbled 38.5% after denying media reports that it is contemplating putting itself up for sale, while First Horizon (FHN) slid 33.2% after Canada's Toronto-Dominion Bank (TD, +1.0%) said regulatory concerns forced it to abandon a plan to buy the Tennessee-based lender.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"At this rate, no regional bank can survive bad news or bad data as a stock price plunge inevitably follows, insured and uninsured deposits are withdrawn and 'pursuing strategic alternatives' means an FDIC shutdown over the coming weekend," wrote Bill Ackman, billionaire investor and hedge fund manager, on Twitter. "And there is no incentive to bid until Sunday after the failure."
Also in focus Thursday was Kenvue (KVUE), which jumped 22.3% in its stock market trading debut. The consumer health products company, whose brands include Band-Aid, Tylenol and Listerine, was spun off from Johnson & Johnson (JNJ, -0.5%) in an initial public offering that priced at $22 per share Wednesday night.
"Johnson & Johnson, a component of the Dow Jones Industrial Average, raised $3.8 billion from the offering," writes Dan Burrows, senior investing editor at Kiplinger.com. "That's the largest haul from an IPO since late 2021, according to Renaissance Capital."
Moderna, Paramount Global report earnings
Other stocks making notable moves on Thursday were Moderna (MRNA), which popped 3.2% after the COVID-19 vaccine maker reported top- and bottom-line beats, and Paramount Global (PARA), which plunged 28.4% after the media giant's Q1 results missed estimates and it slashed its dividend payment.
As for the major indexes, the Dow Jones Industrial Average fell 0.9% to 33,127, the S&P 500 slid 0.7% to 4,061, and the Nasdaq Composite gave back 0.5% to 11,966.
The best low-volatility strategies
As we've said several times recently, volatility in the stock market is likely to stick around for a while. On the immediate horizon are an earnings report this evening from mega-cap tech giant Apple (AAPL), as well as the monthly jobs report tomorrow morning. And next week brings the latest inflation figures, with the April consumer price index (CPI) due out Wednesday a.m. Longer term, continued instability in the banking industry, heightened recession fears and a looming debt-ceiling standoff could all spark wild swings in stocks.
Investors looking to hedge against market uncertainty can check out the best low-volatility stocks or the best low-volatility ETFs, both of which can help add ballast to a portfolio during periods of instability.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at Schaeffer's Investment Research. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
How Another Trump Presidency Will Impact the Stock Market in 2025
President Trump will have little direct impact on the stock market, but his policies, initiatives and posts certainly can make prices move. Here's how.
By Karee Venema Published
-
Stock Market Today: Stocks Are Mixed Ahead of CPI
Cool wholesale inflation numbers provide only slight relief before Wednesday's release of December Consumer Price Index data.
By David Dittman Published
-
Stock Market Today: Dow Leads as UnitedHealth Stock Pops
UnitedHealth was the best Dow Jones stock Monday on reports that Medicare Advantage payments could rise in 2026.
By Karee Venema Published
-
Stock Market Today: Stocks End Mixed After FOMC Minutes
The minutes from the December Fed meeting signaled central bankers' uncertainty over potential Trump administration policies.
By Karee Venema Published
-
Moderna Stock Is Volatile Amid Bird Flu Developments
Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you need to know.
By Joey Solitro Published
-
Stock Market Today: Stocks Dragged Down by Strong Data
Investors weigh the prospect of no more rate cuts in the current cycle.
By David Dittman Published
-
Investing Moves to Make at the Start of the Year
After another big year for stocks in 2024, investors may want to diversify in 2025. Here are five portfolio moves to make at the start of the year.
By Jeff Reeves Published
-
Stock Market Today: Dow Sinks 333 Points as Mega Caps Slide
The main indexes sold off at the open and stayed lower through the close, putting the Santa Claus rally at risk.
By Karee Venema Published
-
Stock Market Today: Dow Dives 1,123 Points After Fed
Market participants reacted predictably to a well-telegraphed hawkish turn by the Federal Reserve.
By David Dittman Published
-
Fed Sees Fewer Rate Cuts in 2025: What the Experts Are Saying
Federal Reserve The Federal Reserve cut interest rates as expected, but the future path of borrowing costs became more opaque.
By Dan Burrows Published